Literature DB >> 1563250

Changes in renal function during acute insulin-induced hypoglycaemia in patients with type 1 diabetes.

A W Patrick1, D A Hepburn, C P Swainson, B M Frier.   

Abstract

The effect of acute hypoglycaemia on renal function was examined in eight male patients with Type 1 diabetes who had normal urinary albumin excretion. Insulin was given as a bolus intravenous injection (0.125 U kg-1) and plasma glucose fell to a nadir of 1.6 (SE 0.2) mmol l-1, with all patients experiencing an acute autonomic reaction. Renal plasma flow fell from 674 (106) to 540 (198) ml min-1 during hypoglycaemia (p less than 0.01) and returned to 655 (181) ml min-1 (NS vs baseline). Glomerular filtration rate (GFR) declined from 143 (23) to 110 (36) ml min-1 during hypoglycaemia (p less than 0.02), rising to 150 (44) ml min-1 in the recovery period (NS vs baseline). The urinary flow rate and urinary albumin excretion rate both fell significantly in response to hypoglycaemia (10.6 (1.2) to 4.7 (1.1) ml min-1; p less than 0.002, and 46.2 (10.6) to 26.0 (10.5) micrograms min-1, respectively). Urinary dopamine excretion also declined, from 322 (37) to 211 (29) mumol min-1 (p less than 0.005) but sodium excretion was unchanged. Plasma adrenaline concentration (0.2 (0.03) to 1.7 (0.4) nmol l-1; p less than 0.01) and plasma renin activity (0.49 (0.13) to 1.08 (0.17) ng-Ang 1 l-1 h-1; p less than 0.01) increased during hypoglycaemia, but changes in plasma noradrenaline and angiotensin II levels did not attain significance. These acute changes in renal function, observed during hypoglycaemia in diabetic patients, may result from direct stimulation of the efferent sympathetic nerves to the kidney, complemented by the hormonal changes induced by hypoglycaemia.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1563250     DOI: 10.1111/j.1464-5491.1992.tb01752.x

Source DB:  PubMed          Journal:  Diabet Med        ISSN: 0742-3071            Impact factor:   4.359


  4 in total

Review 1.  SGLT-2 inhibitors and cardiovascular risk: proposed pathways and review of ongoing outcome trials.

Authors:  Silvio E Inzucchi; Bernard Zinman; Christoph Wanner; Roberto Ferrari; David Fitchett; Stefan Hantel; Rosa-Maria Espadero; Hans-Jürgen Woerle; Uli C Broedl; Odd Erik Johansen
Journal:  Diab Vasc Dis Res       Date:  2015-01-14       Impact factor: 3.291

2.  Association of hypoglycemia with incident chronic kidney disease in patients with type 2 diabetes: a nationwide population-based study.

Authors:  Chia-Jen Shih; Yueh-Lin Wu; Yuan-Hao Lo; Shu-Chen Kuo; Der-Cherng Tarng; Chih-Ching Lin; Shuo-Ming Ou; Yung-Tai Chen
Journal:  Medicine (Baltimore)       Date:  2015-04       Impact factor: 1.889

Review 3.  An evidence-based practice-oriented review focusing on canagliflozin in the management of type 2 diabetes.

Authors:  Joseph A Messana; Stanley S Schwartz; Raymond R Townsend
Journal:  Vasc Health Risk Manag       Date:  2017-02-17

4.  Presence of macroalbuminuria predicts severe hypoglycemia in patients with type 2 diabetes: a 10-year follow-up study.

Authors:  Jae-Seung Yun; Sun-Hye Ko; Sun-Hee Ko; Ki-Ho Song; Yu-Bae Ahn; Kun-Ho Yoon; Yong-Moon Park; Seung-Hyun Ko
Journal:  Diabetes Care       Date:  2012-12-17       Impact factor: 19.112

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.